2013, Number 607
<< Back Next >>
Rev Med Cos Cen 2013; 70 (607)
Artritis reumatoide
Morales LA
Language: Spanish
References: 17
Page: 523-528
PDF size: 297.89 Kb.
ABSTRACT
Rheumatoid Arthritis (RA)
is an autoimmune syndrome,
characterized by a chronic
inflammation of joints. This
disease affects 1 % of the
population and possesses a
high level of morbidity. In his
etiology there affect diverse
environmental, genetic and
immunological factors. Several
cellular lineages of the immune
system improve the chronic
inflammation developed in
articulations, mainly T cells.
The treatment of RA consists of
medicines that calm the pain, and
that are indicated opportunely
by means of the decrease of
the inflammation, controlling
this way the progression of
the injured to articulate,
nevertheless many people
present the disadvantage of
presenting adverse effects. With
the advances at autoimmunity’s
area, new variants of treatments
have developed for these
illnesses. Pathogenesis of
rheumatoid arthritis had been
thoroughly studied, and main
molecules involved in this
process had been elucidated,
which constitute therapeutic
focus for the treatment of this
autoimmune disorder.
REFERENCES
Ábalos M. et al. Calidad de vida relacionada con la salud tras terapia anti-factor de necrosis tumoral alfa en pacientes con artritis reumatoide. Reumatol Clin. 2011:7(3): 167-171.
Asociación Costarricense de Reumatología. Guías de manejo de la artritis reumatoide. Acta méd. costarric [online]. 2011, vol.53, suppl.1, pp. 19- 25. ISSN 0001-6002.
Carretero C. Artritis reumatoide nuevas perspectivas farmacológicas. OFFARM. Vol. 26 Núm 4 Abril 2007.
Carretero C. Artritis Reumatoide diagnóstico y tratamiento. OFFARM. Vol. 27 Núm 4 Abril 2008.
Castañeda S. et al. Diferencias en el manejo de la artritis reumatoide precoz y establecida. Reumatol Clin. 2011:7(3):172-178.
Chavez L.et al. Agudeza diagnostica del examen físico de rodilla en la artritis reumatoide: estudio clínico y sonografica del derrame articular y quiste de Baker. Reumatol Clin. 2007;3(3):98-100.
James T. Jr, Shelley B. Emerging Trends in Diagnosis and Treatment of Rheumatoid Arthritis. Prim Care Clin Office Pract 37 (2010) 779–792.
Kochi et al. Genetics of rheumatoid arthritis: Underlying evidence of ethnic differences. Journal of Autoimmunity 32 (2009) 158–162.
Lorenzo. Rheumatoid Arthritis. Foot Ankle Clin N Am 12 (2007) 525–537.
McInnes, Schett.Mechanisms of Disease. The Pathogenesis of Rheumatoid Arthritis.N Engl J Med 2011;365:2205- 19.
Pratt,et al. Current concepts in the pathogenesis of early rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 23 (2009) 37–48.
Robustillo V, Rodriguez M. ¿Son útiles los factores pronóstico en la artritis reumatoide?. Reumatol Clin. 2011:7(5):339-342.
Royal Australian College of General Practitioners.Clinical guideline for the diagnosis and management of early rheumatoid arthritis. Approved by NHMRC on 12 june 2009. ACN 000 223 807, ABN 34 000 223 807.
Scott,Wolfe. Rheumatoid arthritis. Lancet 2010; 376: 1094–1108.
Tercero G., Olalla H. Artritis Reumatoide. Clínica y Arsenal Farmacoterapéutico. OFFARM. vol 29 núm 4 Julio-Agosto 2010.
Torres et al. Principales estrategias terapéuticas en el tratamiento de la artritis reumatoide. Rev CENIC Ciencias Biológicas, Vol. 39, No. 3, 2008.
Villaverde G.,Balsa C. ¿El control precoz de la artritis reumatoide augura un mejor pronóstico a largo plazo? Reumatol Clin. 2010;6(2),IO6-Î 10.